JP2008527039A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008527039A5 JP2008527039A5 JP2007552193A JP2007552193A JP2008527039A5 JP 2008527039 A5 JP2008527039 A5 JP 2008527039A5 JP 2007552193 A JP2007552193 A JP 2007552193A JP 2007552193 A JP2007552193 A JP 2007552193A JP 2008527039 A5 JP2008527039 A5 JP 2008527039A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- aryl
- heterocyclyl
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64490705P | 2005-01-19 | 2005-01-19 | |
| PCT/US2006/001365 WO2006078575A2 (en) | 2005-01-19 | 2006-01-13 | Fluorinated aminoalkyl-4-oxo-3,4-dihydropyrido[3,4- d] pyrimidines as inhibitors of mitotic kinesins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008527039A JP2008527039A (ja) | 2008-07-24 |
| JP2008527039A5 true JP2008527039A5 (https=) | 2009-02-26 |
Family
ID=36692759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007552193A Withdrawn JP2008527039A (ja) | 2005-01-19 | 2006-01-13 | 有糸分裂キネシン阻害剤としてのフッ素化アミノアルキル−４−オキソ−３，４−ジヒドロピリド［３，４−ｄ］ピリジン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7632839B2 (https=) |
| EP (1) | EP1855664A4 (https=) |
| JP (1) | JP2008527039A (https=) |
| CN (1) | CN101193637A (https=) |
| AU (1) | AU2006206652A1 (https=) |
| CA (1) | CA2595130A1 (https=) |
| WO (1) | WO2006078575A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2346988T3 (pl) * | 2008-10-31 | 2017-10-31 | Janssen Biotech Inc | Różnicowanie ludzkich zarodkowych komórek macierzystych do linii endokrynnej trzustki |
| UY32922A (es) * | 2009-10-06 | 2011-04-29 | Bayer Schering Pharma Ag | Derivados de 3, 5-diciano-4-(1h-indazol-5-il)-2,6-dimetil-1,4-dihidropiridina fluoro-sustituidos y procedimientos de uso de los mismos |
| RU2013114390A (ru) | 2010-08-31 | 2014-10-10 | СНУ Ар энд ДиБи ФАУНДЕЙШН | Применение фетального репрограммирования посредством ppar-дельта-агониста |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| MX2021012208A (es) | 2013-10-04 | 2023-01-19 | Infinity Pharmaceuticals Inc | Compuestos heterocíclicos y usos de los mismos. |
| NZ724368A (en) | 2014-03-19 | 2023-07-28 | Infinity Pharmaceuticals Inc | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| EP4585268A3 (en) | 2015-09-14 | 2025-10-15 | Twelve Therapeutics, Inc. | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005530806A (ja) * | 2002-05-23 | 2005-10-13 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂キネシン阻害薬 |
| EP1513820A4 (en) * | 2002-05-23 | 2006-09-13 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| EP1680420A4 (en) * | 2003-11-07 | 2008-09-24 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
-
2006
- 2006-01-13 WO PCT/US2006/001365 patent/WO2006078575A2/en not_active Ceased
- 2006-01-13 US US11/795,435 patent/US7632839B2/en not_active Expired - Fee Related
- 2006-01-13 EP EP06718442A patent/EP1855664A4/en not_active Withdrawn
- 2006-01-13 CN CNA2006800025587A patent/CN101193637A/zh active Pending
- 2006-01-13 AU AU2006206652A patent/AU2006206652A1/en not_active Abandoned
- 2006-01-13 CA CA002595130A patent/CA2595130A1/en not_active Abandoned
- 2006-01-13 JP JP2007552193A patent/JP2008527039A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008527038A5 (https=) | ||
| Lang et al. | Nitrogen-containing heterocycles as anticancer agents: An overview | |
| JP5931982B2 (ja) | （ａ）ホスホイノシタイド３−キナーゼ阻害剤および（ｂ）Ｒａｓ／Ｒａｆ／Ｍｅｋ経路のモジュレーターの配合物 | |
| JP2022088616A (ja) | 再発性神経膠腫および進行性の二次性脳腫瘍からなる群から選択される悪性腫瘍の治療に使用するための薬剤の調製方法 | |
| EP4161511A1 (en) | Novel small molecules for targeted degradation of untargetable kras in cancer therapy | |
| JP2018531983A (ja) | タンパク質分解誘導キメラ化合物ならびにその調製方法および使用方法 | |
| JP2009514881A5 (https=) | ||
| US20090054415A1 (en) | Combinations, methods and compositions for treating cancer | |
| JP2009514880A5 (https=) | ||
| RU2017104909A (ru) | Лечение рака комбинацией лучевой терапии, наночастиц оксида церия и химиотерапевтического средства | |
| JP2007517071A5 (https=) | ||
| JP2018504418A5 (https=) | ||
| JP2009541223A5 (https=) | ||
| JP2009516653A5 (https=) | ||
| JP2006503919A5 (https=) | ||
| JP2020523354A5 (https=) | ||
| JP2008527039A5 (https=) | ||
| KR20130048293A (ko) | 단백질 키나제 억제제로서의 헤테로아릴 화합물 및 조성물 | |
| RU2015108755A (ru) | Комбинация ингибитора pik3 и ингибитора с-мет | |
| JPWO2020163823A5 (https=) | ||
| RU2014150860A (ru) | Режим дозирования pi-3 киназы | |
| MX2007004549A (es) | Tratamiento combinado con bortezomib y un inhibidor de cinasa del receptor del factor de crecimiento epidermico. | |
| JP2008527041A5 (https=) | ||
| JP2013511526A5 (https=) | ||
| TW202102216A (zh) | 抗腫瘤組合物 |